MSG's expertise is committed to offering long-term support to our healthcare clients to tackle short-term and long-term challenges and issues to transform the operation risk-free worldwide.
Currently, the healthcare sector witness unprecedented challenges that are changing the focus for the policymakers, payers, providers, and suppliers to rethink. MSG's business consultant and market researcher teams are continuous in-talk with healthcare organizations and companies to evaluate the COVID-19 change and further uniquely positioned to provide updated reports and strategic support to our clients to restructure the business model.
MSG's global healthcare team is dedicated to providing updates related to health IT, digital innovation & transformation, cost optimization techniques, clinical performance improvement, strategy development, market development, market developments, product commercialization, and market estimations & projections. This information under one compiled report is making us the leading provider of quality healthcare research reports.
Today, emerging healthcare technologies are helping companies to respond and get ahead of COVID-19 quickly, but also prepare for the new future reality in the global market.
Mar 2024 | Healthcare & Pharmaceutical
Metal in Medicine Market by Metal Type (Copper, Sodium, Gold, Zinc, and Silver), by Administration Route (IV and Oral), by Form (Liquid, Powder, and Tablet), by Application (Fatigue and Dysentery, Alzheimer’s Disease, Hypogeusia, Cancer), by Purchase Type, by Region – Global Share and Forecast to 2030
Mar 2024 | Healthcare & Pharmaceutical
Computer-Aided Drug Discovery Market by Type (Structure-Based Drug Design, Ligand-Based Drug Design, and Sequence-Based Approaches), by Therapeutic Area (Neurology, Oncology, Cardiovascular Disease, Respiratory Disease, and Diabetes), by End-User, by Region – Global Share and Forecast to 2030
Mar 2024 | Healthcare & Pharmaceutical
Nomegestrol Acetate Drugs Market by Type (Menstrual Disturbances, Dysmenorrhea, Premenstrual Syndrome), by End User (Hospitals, Clinics, Ambulatory Surgical Centers), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
RNA Analysis Market by Product (Reagents/Consumables, Instruments, Software), by Technology (Microarrays, Sequencing, Polymerase Chain Reaction-PCR, RNA Interference), by Application (Clinical Diagnostics, Drug Discovery, and Others), by End User, by Region – Global Share and Forecast to 2030
Mar 2024 | Healthcare & Pharmaceutical
Restorative Dentistry Market by Product Type (Restorative Materials, Implants, Prosthetics Materials, Restorative Equipment), by Application (Conservative and Endodontics, Implantology, Prosthodontics, Other Applications), by End User, by Region – Global Share and Forecast to 2030
Mar 2024 | Healthcare & Pharmaceutical
Ustekinumab Market by Indication (Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis), by Dosage Form (Capsule, Tablets), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Etifoxine Market by Application (Anxiety Disorders, Insomnia, and Alcohol Withdrawal Syndrome (AWS)), by Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and by Region (North America, Europe, Asia Pacific, and Others) – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Hydroxyethyl Starch Solutions Market by Product Type (6% Hydroxyethyl Starch Solutions, 10% Hydroxyethyl Starch Solutions, 20% Hydroxyethyl Starch Solutions, Others), by End-User, by Application (Volume Expansion, Blood Volume Substitution), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Pholcodine Market by Product Type (Over-the-counter (OTC) and Prescription Drug), Age Group (Adult and Pediatric), by Dosage Form (Syrup, Tablet, and Others), by Distribution Channel (Hospital, Retail Pharmacy, Online Pharmacy, and Others), and by Region – Global Share and Forecast to 2033
Mar 2024 | Healthcare & Pharmaceutical
Infliximab Market by Product Type (Remsima, Inflectra, and Other Biosimilars), by Indication (Crohn's Disease, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Psoriatic Arthritis, Plaque Psoriasis), by Distribution Channel, and by Region – Global Share and Forecast to 2033